MD, PhD
Lars Lykke Hermansen
Dept. of Orthopedics, University Hospital of Southern Denmark, Esbjerg
| Projekt styring | ||
| Projekt status | Open | |
| Data indsamlingsdatoer | ||
| Start | 17.11.2024 | |
| Slut | 17.11.2027 | |
A Quick pathway for patients with high pRobability of dislocatEd hemi- or total hip arthroplasty to minimize the time from hospital aDmission to redUCtion of the prosthEsis
Short summary
The purpose of this study is to design a fast-track pathway for patients with high probability of having a dislocated hip prosthesis with the primary aim to reduce the time from arrival to reduction and the total hospitalization time. Secondary aims are to investigate whether quicker prosthesis reduction influences on hip function and quality of life afterwards; reduce the pain experience immediately and in the long term; increase patient satisfaction.
Rationale
Patients with total hip arthroplasties and hemiarthroplasties are both subject to hip dislocations. Although the complication incidence is different, both patient groups suffer immediate high pain and needs acute treatment. The purpose of this study is to design a fast-track pathway for patients with a dislocated hip prosthesis primarily to reduce the time from arrival to reduction and the total hospitalization time. Secondary to investigate whether quicker prosthesis reduction influences on hip function and quality of life afterwards; reduce the pain experience immediately and in the long term; and increase patient satisfaction.
Description of the cohort
The study is a prospective observational cohort trial, adhering to the STROBE guidelines. The study is conducted at the University Hospital of Southern Denmark, Esbjerg, as a collaboration between the Department of Orthopedics, Department of Anesthesiology, Department of Radiology, and Department of Emergency. All patients admitted with a dislocated THA or HA will be included in the study without prior informed consent. The patients are - disregard of cognitive status - admitted with a complication that requires acute treatment. After the acute treatment (reduction of the dislocated prosthesis), the patients are informed about the study and encouraged to participate in the second part of the study The study is planned to start November 17, 2024, and will continue for two years. During the first year, the admitted patients will follow the current standard treatment pathway. After November 16, 2025, a newly developed treatment pathway (Fast-track) will be adhered to. Based on a sample size calculation, 120 patients will be included.
Data and biological material
Primary outcomes (time to reduction, total hospitalization) are registered from patient files. The patients are followed for 1 year to measure patient reported outcomes.